SELECTBIO Conferences Circulating Biomarkers World Congress 2017

Circulating Biomarkers World Congress 2017
Venue: Wyndham Boston Beacon Hill, Boston, MA, USA
Date: 20 - 21 March, 2017


Keynote Speakers

Steve Soper

Steve Soper
Foundation Distinguished Professor, Director, Center of BioModular Multi-scale System for Precision Medicine, The University of Kansas

Minetta Liu

Minetta Liu
Associate Professor and Chair, Oncology Research, Mayo Clinic

Xandra Breakefield

Xandra Breakefield
Professor, Mass General Hospital (MGH)/Harvard Medical School

Phil Stephens

Phil Stephens
Chief Scientific Officer, Foundation Medicine

David Wong

David Wong
Director, University of California Los Angeles

Gyongyi Szabo

Gyongyi Szabo
Professor, University of Massachusetts Medical School

Walter Koch

Walter Koch
Vice President, Roche Molecular Systems

Shannon Stott

Shannon Stott
Assistant Professor, Massachusetts General Hospital & Harvard Medical School

Peter  Quesenberry

Peter Quesenberry
Professor of Medicine, The Warren Alpert Medical School of Brown University

Chwee Teck Lim

Chwee Teck Lim
Professor, National University of Singapore

Sehyun Shin

Sehyun Shin
Professor & Director, Korea University

John Sninsky

John Sninsky
Chief Scientific Officer, CareDx

Lynn Sorbara

Lynn Sorbara
Program Director, National Cancer Institute

Jan Lötvall

Jan Lötvall
Professor Krefting Research Centre, University of Gothenburg, Chief Scientist, Codiak BioSciences

Dominique PV de Kleijn

Dominique PV de Kleijn
Professor, National University of Singapore

Clark Chen

Clark Chen
Co-Director, University of California-San Diego

Overview

Select Biosciences, Inc. Fourth Annual Circulating Biomarkers World Congress 2017 brings together the most up-to-date technologies and advances in this expanding and evolving field.  Our coverage in this conference focuses on the various classes of circulating biomarkers:
  • Extracellular Vesicles (EVs): Exosomes and Microvesicles
  • Circulating Nucleic Acids: Circulating Cell-Free DNA, Circulating RNAs
  • Circulating Rare Cells in the Circulation
This conference features speakers from academia as well as industry addressing the following topic areas:
  • Technologies for Isolation and Characterization
  • Role in Cancer and Various Disease Classes
  • Biomarker Potential for Diagnostics Development
  • Therapeutics Potential and Technology Advances in the EV Field
Registered delegates receive access to the co-located concurrent conference tracks, the co-located exhibit hall featuring companies providing tools and technologies address the circulating biomarkers field.

Agenda and Information for:


Exhibition Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks
Choose your language
Japanese
Traditional Chinese
Simplified Chinese
Korean

Industry Event Calendar
Search for Pharmaceuticals